Virtu Financial LLC Satsuma Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
BUY
$4.19 - $7.95 $42,302 - $80,263
10,096 New
10,096 $61,000
Q1 2021

May 19, 2021
SELL
$4.57 - $7.18 $46,307 - $72,754
-10,133 Closed
0 $0
Q4 2020

Feb 24, 2021
SELL
$3.56 - $5.09 $102,987 - $147,248
-28,929 Reduced 74.06%
10,133 $47,000
Q3 2020

Dec 11, 2020
BUY
$3.85 - $28.47 $150,388 - $1.11 Million
39,062 New
39,062 $152,000

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email